Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Difficult-to-treat Rheumatoid Arthritis”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableLooking for participantsNCT07491016
What this trial is testing

Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis

Who this might be right for
TelitaciceptTreatment ComplianceRheumatoid Arthritis
Zhejiang Provincial People's Hospital 30
Not applicableUnknownNCT05671627
What this trial is testing

Cortisol Circadian Rhythm in Patients With RA

Who this might be right for
Rheumatoid Arthritis
National and Kapodistrian University of Athens 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06754462
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Immunovant Sciences GmbH 120
Very early researchWithdrawnNCT07315503
What this trial is testing

An Open-label Study of GC012F in Rheumatoid Arthritis.

Who this might be right for
Rheumatoid Arthritis
Institute of Hematology & Blood Diseases Hospital, China
Not applicableUnknownNCT06215638
What this trial is testing

An Exploratory Clinical Study on Bortezomib for the Treatment of Refractory Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06475495
What this trial is testing

Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Charite University, Berlin, Germany 13
Testing effectiveness (Phase 2)Looking for participantsNCT07796516
What this trial is testing

Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis

Who this might be right for
Difficult-to-treat Rheumatoid ArthritisRheumatoid Arthritis
Peking University People's Hospital 420
Testing effectiveness (Phase 2)Looking for participantsNCT07473154
What this trial is testing

Controlling Hyperactive Immunity With Long-lived Lymphocytes

Who this might be right for
Diffuse Cutaneous Systemic SclerosisRheumatoid Arthritis (RA)Systemic Sclerosis (SSc)+1 more
Quell Therapeutics Limited 16
Not applicableLooking for participantsNCT07484243
What this trial is testing

Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Rheumatoid Arthritis-Associated Interstitial Lung DiseaseDifficult-to-Treat Rheumatoid Arthritis
Dongyi He 10,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT07048197
What this trial is testing

Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease

Who this might be right for
Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD)
Novartis Pharmaceuticals 27